Collaboration in more than 46 countries.

You are leaving the country website to access another site in the group. Regulatory constraints and medical practices vary from country to country. Consequently, the information provided on the site in which you enter may not be suitable for use in your country.

NORTH AMERICA

Canada

United States

LATIN AMERICA

Argentina

Brazil

Mexico

Perú

GLOBAL

CEVA Global

EMEA (REGIONAL)

Denmark

Egypt

France

Germany

Hungary

Italy

Netherlands

Poland

Portugal

Romania

South Africa

Spain

Sweden

Tunisia

Turkey

Ukraine

United Kingdom

ASIA PACIFIC

Asia Pacific (Regional)

CHINA

India

Indonesia

Japan

Korea

Malaysia

Philippines

Share on:

Ceva as Gold Sponsors at EMAC-6 Conference in Edinburgh

Ceva is proud to announce its pivotal role as Gold Sponsors at the sixth edition of the European Meeting of Animal Chlamydioses (EMAC-6). The highly anticipated event is scheduled for November 28-29, 2023, at the prestigious Royal College of Physicians of Edinburgh (RCPE). 

EMAC-6 conference is organized by the European Society of Animal Chlamydioses and associated Zoonoses (ESACZ). ESACZ aims to foster collaboration, research, and knowledge exchange among experts and enthusiasts from across the globe, addressing advancements in the field of animal chlamydioses and associated zoonoses. 

Why Addressing Chlamydophila is so Important

The most frequently diagnosed cause of abortion in UK sheep is enzootic abortion (EAE), caused by the bacteria Chlamydophila abortus. The prevalence of EAE is staggering, with rates reaching 33.8%1 and increasing to 47.6% in flocks exceeding 150 animals. This widespread problem is estimated to cost the sheep industry over £152 million per annum. 

The financial implications extend beyond the loss of aborted lambs, encompassing costs associated with investigating abortion storms (including vet and laboratory fees), barren ewes (loss of ewe herself and the cost of replacement), and disposal fees. Medicines to treat suitable ewes, extra labour costs, and increased mortality/morbidity of weak lambs. Furthermore, reduced milk yield in affected ewes adds to the economic strain. 

Importantly, Chlamydophila abortus poses a risk to human health, underscoring the urgency of addressing this issue comprehensively. 

Prevention is Key: The Role of Vaccination

Prevention via vaccination emerges as the most effective form of control for enzootic abortion. Cevac Chlamydia is an effective vaccine provided by Ceva to safeguard flocks against the devastating impact of Chlamydophila abortus on their reproductive performance. This proactive approach not only protects the health and well-being of the animals but also safeguards the economic interests of sheep farmers. 

By vaccinating with Cevac Chlamydia, farmers can significantly reduce the risk of abortion storms, minimizing financial losses, and promoting the overall productivity and sustainability of their flocks. Ceva emphasizes the importance of taking preventive measures to secure the future of ruminant health and the sheep farming industry. 

A Commitment to ruminant health

Ruminant Ceva’s presence as Gold Sponsors at the EMAC-6 conference underscores the company’s commitment to advancing the understanding and prevention of animal chlamydioses. By actively addressing the challenges posed by Chlamydophila abortus, Ceva continues to lead the way in innovative solutions for ruminant health, contributing to a sustainable and resilient future for the industry. 

Find out more information here. 

Sources:

  • 1Longbottom, 2012
  • 2Mearns, 2007
This site is registered on wpml.org as a development site.